SpineGuard announced the filing of its 510K regulatory dossier with the FDA, seeking the authorization to commercialize its Threaded PediGuard device for anterior approach instrumented spine surgery.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1578 EUR | +0.51% | -3.90% | -20.94% |
07-17 | SpineGuard Files Its 510K Dossier in the Us for the Clearance of Its New Smart Drilling Device Dedicated to Sacroiliac Joint Fusion | CI |
07-16 | SpineGuard: growth accelerates in Q2 | CF |
1st Jan change | Capi. | |
---|---|---|
-20.94% | 9.23M | |
+75.69% | 12.57B | |
-19.21% | 7.88B | |
-7.03% | 5.8B | |
+10.32% | 5.26B | |
-16.50% | 4.84B | |
-11.56% | 4.37B | |
+17.06% | 4.19B | |
-9.70% | 3.41B | |
+28.00% | 2.06B |
- Stock Market
- Equities
- ALSGD Stock
- News SpineGuard
- SpineGuard Files its “510K” Dossier for the Clearance of its “Threaded PediGuard” in Anterior Approach Spine Surgery